EXPLAINED: 11 | Vintage Vibes

CDC advisers delay vote on restricting infant hepatitis B vaccinations in tense meeting

From 1990 to 2019, reported cases of acute hepatitis B among kids declined by 99% due to infant immunization

The Guardian - US · Dec 4, 2025

‘Never seen anything like this’: alarm at memo from top US vaccine official

Vinay Prasad memo said at least 10 children had died from Covid vaccination – but offered scant evidence for claim

The Guardian - US · Dec 4, 2025

‘Doctors said my dad would be ok after getting Covid. It turned out his illness was terminal’

Father-of seven William Chapman only discovered he had deadly pulmonary fibrosis when his GP – who thought he already knew his prognosis – mentioned it during a phone call

The Independent UK · Dec 4, 2025

FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up.

International Business Times UK · Nov 30, 2025

Experts say strict new FDA protocol for vaccine approval is ‘dangerous and irresponsible’

Lead FDA vaccine regulator announced new approval process after claiming Covid vaccine had killed 10 children

The Guardian - US · Nov 29, 2025

Top FDA official threatens to crack down on vaccine approvals

The internal memo comes after an internal agency review linked COVID-19 vaccines to the deaths of 10 children.

Axios · Nov 29, 2025

Louisiana official who called Covid-19 vaccines ‘dangerous’ given key CDC post

Ralph Abraham appointed deputy director as RFK Jr continues to reshape US federal health leadership

The Guardian - US · Nov 25, 2025

Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk

The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) Cohort 8 of ENDEAVOR (Study 9001-103).

Benzinga · Nov 25, 2025

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer AG (OTC:BAYRY) released topline results from the Phase 3 OCEANIC-STROKE study, with its investigational, once daily, oral FXIa inhibitor asundexian.

Benzinga · Nov 24, 2025

Harvard Study Reveals Eight Distinct Long Covid Trajectories as 20M Americans Still Battle Symptoms

Harvard researchers have identified eight long COVID trajectories in a major NIH-backed study, offering new insight into how symptoms change over 15 months.

International Business Times UK · Nov 24, 2025